Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03835533
Title Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations (PORTER)
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Parker Institute for Cancer Immunotherapy
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.